drugset
drugset / Trial / NCT03768466

Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment

NCT03768466 ↗

Phase 4 Completed 123 enrolled Mundipharma Korea Ltd
NaSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to evaluate the efficacy of the study drug (Targin®) after 8 weeks of treatment in patients with moderate to severe low back pain who are uncontrolled\* by NSAIDs.

Timeline

Start
2018-11-21
Primary completion
2020-02-20
Completion
2020-09-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxycodone/Naloxone Unknown — Oral

Indications

No indication recorded.